Novo Holdings, a leading global healthcare and life sciences investor, has announced a strategic minority investment in ...
China Medical System Holdings has announced that initial prescriptions for Silevimig Injection have been issued at multi...
Accro Bioscience and Fosun Pharma are preparing to advance AC-201 into a Phase II/III clinical trial in China for non-se...
Ascletis Pharma has initiated a US Phase I clinical study of ASC36 oral tablets, an investigational amylin receptor pept...
Kelun-Biotech has reported positive interim Phase II results for SKB378/WIN378, an investigational ultra-long-acting mon...
Alebund Pharmaceuticals has received clearance from the US Food and Drug Administration for the Investigational New Drug...
Everest Medicines has received approval from China’s National Medical Products Administration for CARDAMYST, or et...
China Medical System Holdings has announced that its subsidiary Dermavon Holdings has received approval from China&rsquo...
The Hong Kong Polytechnic University (PolyU) and Hangzhou Diagens Biotechnology Co (Diagens Tech) have officially establ...
Everest Medicines has announced that China’s National Medical Products Administration has accepted the Biologics L...
Hutchmed (China) has announced that its subsidiary, Hutchmed Limited has entered into an exclusive development and ...
Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a...
Ascletis Pharma has dosed the first participant in its global Phase III clinical programme evaluating ASC30, an investig...
Medtronic, a global leader in healthcare technology, has announced a strategic partnership with Hong Kong based startup ...
Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensin...
Shanghai-based DualityBio has entered a global collaboration and licensing agreement with Genentech to develop next-gene...
CanSino Biologics reported continued momentum in its international business during the first half of 2026, alongside pro...
Fosun Pharma continued to strengthen its innovation-led growth strategy in the first half of 2026, supported by increasi...
Alebund Pharmaceuticals has reported progress across its renal disease portfolio, including completion of enrolment in a...
AUScelerate and the Shanghai Center of Biomedicine Development have signed a Memorandum of Understanding (MoU) to build ...
The global AI debate is often framed as a choice between acceleration and restraint: innovate first and regulate later, ...
The Hong Kong Polytechnic University (PolyU) and the University of Oxford, UK have signed a Memorandum of Understanding ...
Haisco Pharmaceutical Group Co. has entered into an exclusive licensing agreement with Sentivera, a new US venture found...
The World Health Organization (WHO) and China's Peking University have entered into a two-year project collaboration agr...
Akeso has received clinical trial clearance from China’s Center for Drug Evaluation for AK157D1, a next-generation...
